Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease

被引：63
|
作者：
Carpentier, AF [1 ]
Bonnet, AM [1 ]
Vidailhet, M [1 ]
Agid, Y [1 ]
机构：
[1] FED NEUROL, PARIS, FRANCE
来源：
NEUROLOGY | 1996年 / 46卷 / 06期
关键词：
D O I：
10.1212/WNL.46.6.1548
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Seven patients suffering from Parkinson's disease (PD) with severely disabling dyskinesia received low-dose propranolol as an adjunct to the currently used medical treatment. There was a significant 40% improvement in the dyskinesia. score without increase of parkinsonian motor disability. Ballistic and choreic dyskinesia were markedly ameliorated, whereas dystonia was not. This study suggests that administration of low doses of beta-blockers may improve levodopa-induced ballistic and choreic dyskinesia in PD.
引用
收藏
页码：1548 / 1551
页数：4
相关论文
共 50 条
  • [21] White matter alterations in Parkinson's disease with levodopa-induced dyskinesia
    Ogawa, Takashi
    Hatano, Taku
    Kamagata, Koji
    Andica, Christina
    Takeshige-Amano, Haruka
    Uchida, Wataru
    Saito, Yuya
    Shimo, Yasushi
    Oyama, Genko
    Umemura, Atsushi
    Iwamuro, Hirokazu
    Ito, Masanobu
    Hori, Masaaki
    Aoki, Shigeki
    Hattori, Nobutaka
    PARKINSONISM & RELATED DISORDERS, 2021, 90 : 8 - 14
  • [22] Pridopidine for the treatment of Levodopa-induced Dyskinesia in patients with Parkinson's disease
    Geva, M.
    McGarry, A.
    Cohen, Y.
    Johnston, T.
    de Somer, M.
    Kieburtz, K.
    Hayden, M.
    Brotchie, J.
    Olanow, C.
    MOVEMENT DISORDERS, 2020, 35 : S396 - S396
  • [23] Levodopa-induced dyskinesia in Parkinson disease: Sleep matters
    Amato, Ninfa
    Manconi, Mauro
    Moeller, Jens C.
    Sarasso, Simone
    Stanzione, Paolo
    Staedler, Claudio
    Kaelin-Lang, Alain
    Galati, Salvatore
    ANNALS OF NEUROLOGY, 2018, 84 (06) : 905 - 917
  • [24] EEG biofeedback training for Parkinson's disease with levodopa-induced dyskinesia
    Erickson-Davis, C.
    Anderson, J.
    Richter, S.
    Wielinski, C.
    Parashos, S.
    MOVEMENT DISORDERS, 2009, 24 : S59 - S59
  • [25] CARDINAL SYMPTOMS OF PARKINSON'S DISEASE COHABIT WITH LEVODOPA-INDUCED DYSKINESIA
    Goubault, E.
    Nguyen, H. P.
    Bogard, S.
    Faucher, G.
    Duval, C.
    PARKINSONISM & RELATED DISORDERS, 2018, 46 : E12 - E12
  • [26] Levetiracetam (Keppra) in the treatment of levodopa-induced dyskinesia in Parkinson's disease
    Zesiewicz, TA
    Sullivan, KL
    Maldonado, JL
    Tatum, WO
    Hauser, RA
    NEUROLOGY, 2004, 62 (07) : A510 - A510
  • [27] Should there be less emphasis on levodopa-induced dyskinesia in Parkinson's disease?
    Chaudhuri, K. Ray
    Jenner, Peter
    Antonini, Angelo
    MOVEMENT DISORDERS, 2019, 34 (06) : 816 - 819
  • [28] The neural mechanisms underlying levodopa-induced dyskinesia in Parkinson's disease
    Brotchie, JM
    ANNALS OF NEUROLOGY, 2000, 47 (04) : S105 - S114
  • [29] Quantitative electroencephalographic profile of Parkinson's disease with levodopa-induced dyskinesia
    Erickson-Davis, C. R.
    Anderson, J. S.
    Wielinski, C. L.
    Parashos, S. A.
    Krohn, S.
    MOVEMENT DISORDERS, 2008, 23 (01) : S300 - S300
  • [30] Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson’s disease
    Alessandra Nicoletti
    Giovanni Mostile
    Giuseppe Nicoletti
    Gennarina Arabia
    Giovanni Iliceto
    Paolo Lamberti
    Roberto Marconi
    Letterio Morgante
    Paolo Barone
    Aldo Quattrone
    Mario Zappia
    Journal of Neurology, 2016, 263 : 888 - 894
12345